QQ客服 官方微博 反馈留言

	The Wnt Signaling Pathway Effector TCF7L2 Mediates Olanzapine-Induced Weight Gain and Insulin Resistance.
	Li, Ranran; Ou, Jianjun; Li, Li; Yang, Ye; Zhao, Jingping; Wu, Renrong*
刊名	Frontiers in pharmacology
	2018
卷号	9期号:APR页码:379
关键词	TCF7L2 Wnt signaling pathway atypical antipsychotics insulin resistance olanzapine weight gain
ISSN号	1663-9812
DOI	10.3389/fphar.2018.00379
URL标识	查看原文
WOS记录号	WOS:000430098700001
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3322303
专题	中南大学
作者单位	1.[Wu, Renrong 2.Li, Li 3.Li, Ranran 4.Yang, Ye 5.Ou, Jianjun 6.Zhao, Jingping] Cent S Univ, Xiangya Hosp 2, Dept Psychiat, Changsha, Hunan, Peoples R China.
推荐引用方式 GB/T 7714	Li, Ranran,Ou, Jianjun,Li, Li,et al. The Wnt Signaling Pathway Effector TCF7L2 Mediates Olanzapine-Induced Weight Gain and Insulin Resistance.[J]. Frontiers in pharmacology,2018,9(APR):379.
APA	Li, Ranran,Ou, Jianjun,Li, Li,Yang, Ye,Zhao, Jingping,&Wu, Renrong*.(2018).The Wnt Signaling Pathway Effector TCF7L2 Mediates Olanzapine-Induced Weight Gain and Insulin Resistance..Frontiers in pharmacology,9(APR),379.
MLA	Li, Ranran,et al."The Wnt Signaling Pathway Effector TCF7L2 Mediates Olanzapine-Induced Weight Gain and Insulin Resistance.".Frontiers in pharmacology 9.APR(2018):379.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。